Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients.

Baseline to 3-months changes in HbA1c based on starting HbA1c (n=262) The data from Table 2 underscores a clear trend where individuals in the case group with the highest initial HbA1c levels (≥9.0%) experienced the most significant HbA1c reduction of -3.67% (p < 0.001).

also in 3,139 other papers